Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China
· Delayed Price · Currency is CNY 29.14
+0.73 (2.57%)
At close: Mar 10, 2026
Tuoxin Pharmaceutical Group Company Description
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China.
It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, azithromycin, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system.
The company was founded in 2001 and is based in Xinxiang, China.
Tuoxin Pharmaceutical Group Co.,Ltd.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,551 |
| CEO | Shaohua Yang |
Contact Details
Address: No. 515, Kelong Avenue, High-tech Zone Xinxiang, 453000 China | |
| Phone | 86 37 3635 1898 |
| Website | tuoxinpharm.com |
Stock Details
| Ticker Symbol | 301089 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004YC3 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Shaohua Yang | GM and Non-Independent Director |
| Huijuan Jiao | Chief Financial Officer |
| Xiuqiang Wang | Deputy GM and Director |
| Yuhua Yang | Board Secretary |
| Tao Li | Deputy General Manager |
| Zhen Wei Yu | Accounting Supervisor |